Semi‐Quantitative Imaging Biomarkers of Knee Osteoarthritis Progression: Data from the FNIH OA Biomarkers Consortium

word count: 244 Body word count: 4,185 Tables and Figures: 4 Correspondence: Jamie E. Collins, PhD Orthopaedic and Arthritis Center for Outcomes Research Department of Orthopaedic Surgery Brigham and Women’s Hospital 75 Francis Street, BC 4-016 Boston, MA 02115 jcollins13@partners.org Phone: (617) 732-5338 Fax: (617) 525-7900

[1]  H. Genant,et al.  Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis. , 2004, Osteoarthritis and cartilage.

[2]  Berkman Sahiner,et al.  On the assessment of the added value of new predictive biomarkers , 2013, BMC Medical Research Methodology.

[3]  G. Hawker,et al.  The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. , 2005, Rheumatology.

[4]  Stanley Lemeshow,et al.  Applied Logistic Regression, Second Edition , 1989 .

[5]  Mads Nielsen,et al.  Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers , 2009, Arthritis research & therapy.

[6]  M. Nevitt,et al.  Predictive validity of within-grade scoring of longitudinal changes of MRI-based cartilage morphology and bone marrow lesion assessment in the tibio-femoral joint--the MOST study. , 2012, Osteoarthritis and cartilage.

[7]  F. Salaffi,et al.  Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls , 2005, Aging clinical and experimental research.

[8]  T. Spector,et al.  OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis. , 2009, Osteoarthritis and cartilage.

[9]  A. Ozonoff,et al.  Volumetric and semiquantitative assessment of MRI-detected subchondral bone marrow lesions in knee osteoarthritis: a comparison of contrast-enhanced and non-enhanced imaging. , 2010, Osteoarthritis and cartilage.

[10]  Kathleen F. Kerr,et al.  Testing for improvement in prediction model performance , 2013, Statistics in medicine.

[11]  M. Nevitt,et al.  Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis , 2008, Annals of the rheumatic diseases.

[12]  Bernadette A. Thomas,et al.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[13]  D. J. Hunter,et al.  Systematic review of the concurrent and predictive validity of MRI biomarkers in OA. , 2011, Osteoarthritis and cartilage.

[14]  Erika Schneider,et al.  The osteoarthritis initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee. , 2008, Osteoarthritis and cartilage.

[15]  G. Stucki,et al.  Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities. , 2002, The Journal of rheumatology.

[16]  A. Guermazi,et al.  The reliability of a new scoring system for knee osteoarthritis MRI and the validity of bone marrow lesion assessment: BLOKS (Boston–Leeds Osteoarthritis Knee Score) , 2007, Annals of the rheumatic diseases.

[17]  F. Eckstein,et al.  Can structural joint damage measured with MR imaging be used to predict knee replacement in the following year? , 2015, Radiology.

[18]  Felix Eckstein,et al.  Cartilage thickness change as an imaging biomarker of knee osteoarthritis progression – data from the fnih OA biomarkers consortium , 2015 .

[19]  D. Dunlop,et al.  Arthritis prevalence and activity limitations in older adults. , 2001, Arthritis and rheumatism.

[20]  M. Nevitt,et al.  Biomarkers for osteoarthritis: current position and steps towards further validation. , 2014, Best practice & research. Clinical rheumatology.

[21]  R. Boudreau,et al.  Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI Osteoarthritis Knee Score). , 2011, Osteoarthritis and cartilage.